BE873973A - Derives de metronidazole et compositions pharmaceutiques en contenant - Google Patents

Derives de metronidazole et compositions pharmaceutiques en contenant

Info

Publication number
BE873973A
BE873973A BE0/193304A BE193304A BE873973A BE 873973 A BE873973 A BE 873973A BE 0/193304 A BE0/193304 A BE 0/193304A BE 193304 A BE193304 A BE 193304A BE 873973 A BE873973 A BE 873973A
Authority
BE
Belgium
Prior art keywords
pharmaceutical compositions
compositions containing
metronidazole
derivatives
metronidazole derivatives
Prior art date
Application number
BE0/193304A
Other languages
English (en)
French (fr)
Inventor
J Biermacher
M Cho
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of BE873973A publication Critical patent/BE873973A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/193304A 1978-02-06 1979-02-06 Derives de metronidazole et compositions pharmaceutiques en contenant BE873973A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/875,393 US4160827A (en) 1978-02-06 1978-02-06 Metronidazole phosphate and salts

Publications (1)

Publication Number Publication Date
BE873973A true BE873973A (fr) 1979-08-06

Family

ID=25365724

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/193304A BE873973A (fr) 1978-02-06 1979-02-06 Derives de metronidazole et compositions pharmaceutiques en contenant

Country Status (16)

Country Link
US (1) US4160827A (xx)
JP (1) JPS54115375A (xx)
AU (1) AU523423B2 (xx)
BE (1) BE873973A (xx)
CA (1) CA1108622A (xx)
CH (1) CH638535A5 (xx)
DE (1) DE2903269A1 (xx)
ES (1) ES477265A1 (xx)
FR (1) FR2416234A1 (xx)
GB (1) GB2013683B (xx)
GR (1) GR67623B (xx)
IT (1) IT1116516B (xx)
NL (1) NL7900858A (xx)
PH (1) PH14464A (xx)
SE (1) SE445221B (xx)
ZA (1) ZA79282B (xx)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4386079A (en) 1981-11-23 1983-05-31 The Upjohn Company Method of treating depression
US4531004A (en) * 1981-11-23 1985-07-23 The Upjohn Company Dimetronidazole phosphates

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1237670A (en) * 1983-05-26 1988-06-07 Andrew S. Janoff Drug preparations of reduced toxicity
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
US4943579A (en) * 1987-10-06 1990-07-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble prodrugs of camptothecin
US7223421B2 (en) * 2000-06-30 2007-05-29 Mcneil-Ppc, Inc. Teste masked pharmaceutical particles
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US6423707B1 (en) 2000-08-28 2002-07-23 California Pacific Medical Center Nitroimidazole ester analogues and therapeutic applications
WO2002076398A2 (en) * 2001-03-27 2002-10-03 R.P. Scherer Technologies, Inc. Improved forms of pharmaceutically active agents and method for manufacture thereof
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
GB0315671D0 (en) * 2003-07-04 2003-08-13 Chelsea And Westminster Nhs Tr Improvements in or relating to organic compounds
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
EP1685114B1 (en) * 2003-10-28 2008-10-15 Ems S.A. Antibacterial and/or antiprotozoal nitroimidazole derivative compounds with urease inhibitor activity, process for preparing these compounds and use in pharmaceutical compositions and medicines.
WO2007039825A2 (en) 2005-05-09 2007-04-12 Foamix Ltd. Saccharide foamable compositions
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
EP2242476A2 (en) 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US8871184B2 (en) 2009-10-02 2014-10-28 Foamix Ltd. Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
CN102516299A (zh) * 2011-12-09 2012-06-27 陕西合成药业有限公司 左旋奥硝唑磷酸酯氨基酸盐及其制备方法和用途
CN102516298A (zh) * 2011-12-09 2012-06-27 陕西合成药业有限公司 左旋奥硝唑磷酸酯稳定的药用盐及其制备方法和用途
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
CN108295039A (zh) * 2018-02-28 2018-07-20 重庆希尔安药业有限公司 甲硝唑***泡腾片及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE571291A (fr) * 1957-09-20 1962-01-12 Rhone Poulenc Sa Nouveaux derives de l'imidazole et leur preparation.
US2944061A (en) * 1957-09-20 1960-07-05 Acyl derivatives and process
GB1280355A (en) * 1969-06-20 1972-07-05 Rech S Et D Applic Scient Et M Substituted 5-nitro-imidazoles and their preparation
FR2054504B1 (xx) * 1969-07-18 1973-06-08 Rhone Poulenc Sa
US3910945A (en) * 1972-10-04 1975-10-07 Searle & Co 2-(2-Methyl-5-nitro-1-imidazolyl)ethyl-N-arylalkyldithiocarbamates
US3882136A (en) * 1973-11-16 1975-05-06 Searle & Co S-{8 omega-(1-imidazolyl) alkyl{9 hydrogen monothiosulfates and salts thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4386079A (en) 1981-11-23 1983-05-31 The Upjohn Company Method of treating depression
US4531004A (en) * 1981-11-23 1985-07-23 The Upjohn Company Dimetronidazole phosphates

Also Published As

Publication number Publication date
GB2013683B (en) 1982-06-30
SE7900952L (sv) 1979-08-07
ZA79282B (en) 1980-01-30
AU523423B2 (en) 1982-07-29
CA1108622A (en) 1981-09-08
GB2013683A (en) 1979-08-15
AU4370579A (en) 1979-08-16
NL7900858A (nl) 1979-08-08
GR67623B (xx) 1981-09-01
US4160827A (en) 1979-07-10
FR2416234B1 (xx) 1983-02-04
DE2903269A1 (de) 1979-08-09
PH14464A (en) 1981-07-29
SE445221B (sv) 1986-06-09
CH638535A5 (de) 1983-09-30
JPS54115375A (en) 1979-09-07
IT7947874A0 (it) 1979-02-02
FR2416234A1 (fr) 1979-08-31
IT1116516B (it) 1986-02-10
ES477265A1 (es) 1980-10-01

Similar Documents

Publication Publication Date Title
BE873973A (fr) Derives de metronidazole et compositions pharmaceutiques en contenant
FR2430410B1 (fr) Phenethanolamines et compositions pharmaceutiques en contenant
BE864726A (fr) Compositions pharmaceutiques contenant de la cholestyramine
MX9203380A (es) Derivados de carbazolil-(4)-oxi-propanolamina y composiciones farmaceuticas que los contienen.
IT8024545A0 (it) Composizioni farmaceutiche topiche contenenti trietilenetetramina eloro metodi di impiego.
FR2290912A1 (fr) Formulations pharmaceutiques contenant de la l-dopa ou ses derives
IT1121238B (it) Derivati di amminotiazoli ad azione farmaceutica
BE873500A (fr) Nouveaux derives de thienohydantoine et composition pharmaceutique les contenant
IT7925182A0 (it) Derivati di spiro-ossazolidindioni e composizioni farmaceutiche che li contengono.
BE892805A (fr) Cycloalcanes substitues et compositions pharmaceutiques les contenant
BE887970A (fr) Nouveaux derives d'ocytocine et compositions pharmaceutiques contenant ces derives
BE888797A (fr) Derives de carnitine et compositions pharmaceutiques en contenant
BE870851A (fr) Composes de thiazole et compositions pharmaceutiques en contenant
FR2347365A1 (fr) Trans-hexahydro-pyrido-indoles, leur preparation et compositions pharmaceutiques les contenant
BE871623A (fr) Nouveaux derives du tetrazole et compositions pharmaceutiques les contenant
BE856319A (fr) Compositions pharmaceutiques renfermant des derives organiques de la montmorillonite
FR2312253A1 (fr) Derives de la piperazine et medicament contenant ces substances
NL7903769A (nl) Di-o-n-alkylglycerolderivaten en farmaceutische preparaten daarvan.
FR2460136B1 (fr) Compositions pharmaceutiques contenant des extraits de lierre grimpant
BE848227A (fr) Nouveaux composes heterocycliques et compositions pharmaceutiques les contenant,
FR2342971A1 (fr) Derives de la purine et medicament contenant ces substances
BE866100A (fr) Derives de composes du type inter-phenylene-prostaglandine et compositions pharmaceutiques en contenant
FR2335228A1 (fr) Derives de la 5-fluoro-pyrimidine-4-one et medicament contenant ces substances
PT77751B (fr) Procede de preparation de derives benzylideniques soufres et de compositions pharmaceutiques le contenant
FR2340310A1 (fr) Hydrazinophtalazines substituees, leur preparation et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: THE UPJOHN CY

Effective date: 19880228